A Phase Ib/IIa Clinical Trial of AsiDNA in Combination with PARP Inhibitors for the Treatment of Solid Tumors
Phase of Trial: Phase I/II
Latest Information Update: 25 Oct 2018
At a glance
- Drugs AsiDNA (Primary) ; Poly(ADP-ribose) polymerase inhibitors
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- Sponsors Onxeo SA
- 25 Oct 2018 According to an Onxeo SA media release, Onxeo plans to start this study as soon as H1 2019.
- 27 Jul 2018 According to an Onxeo SA media release, this trial is expected to start early 2019.
- 17 Jul 2018 New trial record